Literature DB >> 34665707

Sonographic features of lymphoma of the major salivary glands diagnosed with ultrasound-guided core needle biopsy in Sjögren's syndrome.

Michele Lorenzon1, Francesco Tulipano Di Franco2, Alen Zabotti3, Enrico Pegolo4, Ivan Giovannini3, Valeria Manfrè3, Elisa Mansutti5, Salvatore De Vita3, Chiara Zuiani2, Rossano Girometti2.   

Abstract

OBJECTIVES: To identify ultrasound (US) features of lymphomas (L) of major salivary glands (SGs) in primary Sjögren's syndrome (pSS) patients and to differentiate US pattern of L and non-L.
METHODS: Prospectively, from September 2019 to March 2021, 27 pSS-patients with clinical findings suspicious for L of the SGs underwent US evaluation followed by US-guided core-needle biopsy (CNB). For each patient, we assessed the OMERACT score, dichotomised (0/1 "lower", 2/3 "higher"), and we compared it between L-pSS and nonL-pSS groups. For focal lesions, echogenicity, inner appearance, shape, margins, presence of septa, vascularisation and posterior acoustic features were also assessed and compared between the two groups; we planned to consider as "suspicious" features more frequently associated with L. We expected to compare frequencies at which two or more "suspicious" features were simultaneously present between L-pSS and nonL-pSS. P<0.05 were considered statistically significant.
RESULTS: L-pSS showed more inhomogeneous glandular pattern (100% vs. 69.2% higher OMERACT; p=0.0407). For focal lesions, the "suspicious" features identified were: OMERACT grade 3, very hypoechoic, homogenous, oval shape, well-defined margins, presence of septa, colour-Doppler vascularization, posterior acoustic enhancement. 6/8 and 7/8 simultaneous suspicious features were significantly higher among L-pSS patients, compared to nonL-pSS (88.9% vs. 28.6%, p=0.034 for 6/8 features; 77.8% vs. 14.3%, p=0.040 for 7/8 features).
CONCLUSIONS: L of the major SGs in pSS was always associated with OMERACT scores 2 or 3 and presented with diffuse or focal patterns. For focal lesions, the association of more "suspicious" features made the diagnosis of L increasingly more likely. This information can help to improve planning of US-guided CNB.

Entities:  

Mesh:

Year:  2021        PMID: 34665707     DOI: 10.55563/clinexprheumatol/4c36nr

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

Review 1.  Sjögren syndrome: looking forward to the future.

Authors:  Sara Zandonella Callegher; Ivan Giovannini; Sabine Zenz; Valeria Manfrè; Martin H Stradner; Alojzija Hocevar; Marwin Gutierrez; Luca Quartuccio; Salvatore De Vita; Alen Zabotti
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-05-23       Impact factor: 3.625

2.  Safety, patient acceptance and diagnostic accuracy of ultrasound core needle biopsy of parotid or submandibular glands in primary Sjögren's syndrome with suspected salivary gland lymphoma.

Authors:  Ivan Giovannini; Michele Lorenzon; Valeria Manfrè; Sara Zandonella Callegher; Enrico Pegolo; Chiara Zuiani; Rossano Girometti; Alojzija Hocevar; Christian Dejaco; Quartuccio Luca; Salvatore De Vita; Alen Zabotti
Journal:  RMD Open       Date:  2022-02

Review 3.  Salivary Gland Ultrasound in Primary Sjögren's Syndrome: Current and Future Perspectives.

Authors:  Michele Lorenzon; Erica Spina; Francesco Tulipano Di Franco; Ivan Giovannini; Salvatore De Vita; Alen Zabotti
Journal:  Open Access Rheumatol       Date:  2022-09-01

Review 4.  Sjögren Syndrome: New Insights in the Pathogenesis and Role of Nuclear Medicine.

Authors:  Anzola Luz Kelly; Rivera Jose Nelson; Ramírez Sara; Signore Alberto
Journal:  J Clin Med       Date:  2022-09-04       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.